Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2349)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (22)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4744)
  2. Department of Medicine (4742)
  3. Center for Pancreatic Cancer Research (2312)
  4. Surgery (1065)
  5. Survivorship Research (1013)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (219)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (147)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (320)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase IB clinical trial of the sequence dependent combination of paclitaxel (P) and cisplatin (C) with the cyclin dependent kinase (CDK) inhibitor flavopiridol in patients with advanced solid tumors
    Meeting Abstract

    Shah, M. A.; Kaubisch, A.; O'reilly, E.; Sharma, S.; Endres, S.; Welch, M.; Tong, W.; Spriggs, D.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save
  • Low Drg1 expression indicates poor survival in patients with metastatic colon cancer
    Meeting Abstract

    Shah, M. A.; Schwartz, G. K.; Drobnjak, M.; Motwani, M. V.; Hummer, A.; Gonen, M.; Cordon-Cardo, C.; Kemeny, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Acne-like rash predicts response in patients treated with Cetuximab (IMC-C225) plus Irinotecan (CPT-11) in CPT-11-refractory colorectal cancer (CRC) that expresses epidermal growth factor receptor (EGFR)
    Meeting Abstract

    Saltz, L.; Rubin, M. S.; Hochster, H. S.; Tchekmeydian, N. S.; Waksal, H. W.; Needle, M. N.; Lobuglio, A. F.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • A phase I/pharmacologic study of UCN-01 in combination with 5-fluorouracil in patients with advanced solid tumors
    Meeting Abstract

    Shah, M. A.; Kortmansky, J.; Kelsen, D. P.; Hseuh, C.; Kaubisch, A.; Spriggs, D.; Gonen, M.; Tong, W.; Endres, S.; Schwartz, G. K.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Irinotecan: A new agent comes of age
    Journal Article

    Saltz, L. B.
    The Oncologist (2001)

    Fulltext@MSK | Save
  • Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer - Authors reply
    Journal Article

    Saltz, L. B.; Miller, L. L.
    New England Journal of Medicine (2001)

    Fulltext@MSK | Save
  • Preoperative chemoradiotherapy for esophageal cancer
    Journal Article

    Kelsen, D.
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Islet cell tumors of the pancreas: The medical oncologist's perspective
    Journal Article

    Brentjens, R.; Saltz, L.
    Surgical Clinics of North America (2001)

    Fulltext@MSK | Save
  • Oral chemotherapy for colorectal cancer: Some economic considerations
    Journal Article

    Saltz, L.
    Oncology (Norwalk) (2001)

    Fulltext@MSK | Save
  • Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: A new survival standard
    Journal Article

    Saltz, L. B.; Douillard, J. Y.; Pirotta, N.; Alakl, M.; Gruia, G.; Awad, L.; Elfring, G. L.; Locker, P. K.; Miller, L. L.
    The Oncologist (2001)

    Fulltext@MSK | Save